SEC Info  
  Home     Search     My Interests     Help     Sign In     Please Sign In  

Wiley John & Sons Inc · 8-K · For 3/2/05

Filed On 3/2/05 9:29am ET   ·   SEC File 1-11507   ·   Accession Number 107140-5-9

  in   Show  and 
Help... Wildcards:  ? (any letter),  * (many).  Logic:  for Docs: (and), (or);  for Text: (anywhere),  "(&)" (near).
  As Of               Filer                 Filing     As/For/On Docs:Pgs

 3/02/05  Wiley John & Sons Inc             8-K{5}      3/02/05    1:3

Current Report   ·   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         McKinnell Retirement From Board                        3      9K 


Document Table of Contents

Page (sequential) | (alphabetic) Top
 
11st Page
2Item 5.02. Departure of Directors or Principal Officers
8-K1st Page of 3TOCTopPreviousNextBottomJust 1st
 
Sponsored Ads...

SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 March 2, 2005 (Date of Report) (Date of earliest event reported) JOHN WILEY & SONS, INC. (Exact name of registrant as specified in its charter) New York (State or jurisdiction of incorporation) 0-11507 13-5593032 -------------------------------------- ---------------------------------- Commission File Number IRS Employer Identification Number 111 River Street, Hoboken NJ 07030 -------------------------------------- ---------------------------------- Address of principal executive offices Zip Code Registrant's telephone number, including area code: (201) 748-6000 -------------- Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): [ ] Written communications pursuant to Rule 425 under the Securities Act(17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act(17 CFR 240.14a-12) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act(17 CFR 240.13e-4(c)) NOT APPLICABLE This is the first page of a three-page document.
8-K2nd Page of 3TOC1stPreviousNextBottomJust 2nd
Item 5.02 Departure of Directors or Principal Officers -------------------------------------------- On March 2, 2005, John Wiley and Sons, Inc ("the Company") announced that Henry A. McKinnell, a non-executive director, has chosen not to stand for re-election to the Board at the Annual Meeting of Shareholders on September 15, 2005, but will serve out his term until then. Dr. McKinnell, who is Chairman of the Board and Chief Executive Officer of Pfizer, Inc., has served on the Company's Board since 1996 and has been Chairman of the Compensation Committee since September 2000. The Company is initiating a search for Dr. McKinnell's replacement.
8-KLast Page of 3TOC1stPreviousNextBottomJust 3rd
Signature Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. John Wiley & Sons, Inc. /S/ William J. Pesce --------------------------------- William J. Pesce President and Chief Executive Officer

Dates Referenced Herein   and   Documents Incorporated By Reference

Referenced-On Page
This 8-K Filing   Date First   Last      Other Filings
Filed On / Filed As Of / For The Period Ended3/2/0512
9/15/0524, DEF 14A
 
TopList All Filings


Filing Submission   -   Alternative Formats (Word / Rich Text, HTML, Plain Text, SGML, XML, et al.)
Sponsored Ads...

Copyright © 2010 Fran Finnegan & Company.  All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri, 19 Mar 05:02:18.0 GMT